Sep 9, 2020 – Podcasts
Developing vaccines is very hard work, as evidenced by Tuesday’s news that AstraZeneca is pausing its clinical trials on a COVID-19 vaccine after a patient appeared to develop a serious neurological condition. And that raises an unsettling question: What if a vaccine is further away than most of us expect?
Axios Re:Cap digs in with Stat News reporter Adam Feuerstein, who helped break the AstraZeneca news.
Tactical Survival Guides
14 Survival Guides and 8 ReportsClick Here to Get Instant Access 24/7
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe